Scarica l'app Stockscreener
22.47
1.03%
0.23
Dopo l'orario di chiusura:
22.47
Spyre Therapeutics Inc Borsa (SYRE) Ultime notizie
Can Spyre Therapeutics Inc. stock sustain free cash flow growthOptions Play & Daily Profit Focused Stock Screening - newser.com
Best data tools to analyze Spyre Therapeutics Inc. stock2025 Retail Activity & Fast Exit Strategy with Risk Control - newser.com
Will Spyre Therapeutics Inc. stock deliver strong dividend growth2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - newser.com
Spyre Therapeutics (SYRE): Valuation Takes Center Stage After Major Capital Raise Bolsters Cash Position - simplywall.st
Spyre Therapeutics Announces Public Stock Offering - MSN
What technical charts say about Spyre Therapeutics Inc. stockJuly 2025 Volume & Low Risk High Reward Ideas - Trung tâm Dự báo KTTV quốc gia
Will Spyre Therapeutics Inc. stock recover faster than peers2025 Analyst Calls & Fast Moving Market Watchlists - newser.com
Spyre Therapeutics Completes $316 Million Public Offering - Global Legal Chronicle
Spyre Therapeutics Inc. stock volume spike explainedWeekly Volume Report & Expert Approved Momentum Trade Ideas - newser.com
Spyre Therapeutics Inc (FRA:3920) Stock Price, Trades & News - GuruFocus
Q1 Earnings Forecast for SYRE Issued By Leerink Partnrs - Defense World
Spyre Therapeutics Closes $316.2 Million Public Offering - MarketScreener
Spyre Therapeutics Closes $316.2 Million Public Offering of Common Stock - Quiver Quantitative
Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.2 Million - The Manila Times
$316.2M Raised — Spyre Therapeutics Closes 17.09M-Share Public Offering, Underwriters Exercised - Stock Titan
What sentiment indicators say about Spyre Therapeutics Inc. stockQuarterly Portfolio Review & Reliable Volume Spike Trade Alerts - newser.com
Spyre Therapeutics (NASDAQ:SYRE) Sees Strong Trading Volume on Analyst Upgrade - Defense World
SYRE completes equity offering; option exercised in full - Stock Titan
Spyre Therapeutics (SYRE): Assessing Valuation Following Major Equity Offering and Share Price Surge - Yahoo Finance
[424B5] Spyre Therapeutics, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
Spyre Therapeutics Stock Rises 11% After $275 Mln Public Offering Pricing - Nasdaq
Spyre Therapeutics announces common stock offering, no amount given - MSN
Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On TuesdayAmerican Resources (NASDAQ:AREC), Albertsons Companies (NYSE:ACI) - Benzinga
Spyre Therapeutics rises after $275 mln equity raise - TradingView
Spyre Therapeutics IncExpects $486.2 million in cash and equivalents as of Sept 30, 2025SEC filing - MarketScreener
SYRE expects ~$486.2M cash and securities; unaudited, preliminary - Stock Titan
Spyre Therapeutics Prices $275 Million Share Offering - MarketScreener
Spyre Therapeutics (NASDAQ:SYRE) Rating Increased to Hold at Wall Street Zen - Defense World
[424B5] – Spyre Therapeutics, Inc. (SYRE) (CIK 0001636282) - Stock Titan
Spyre Therapeutics prices public offering at $18.50 per share By Investing.com - Investing.com Nigeria
SYRE Stock Offering Priced Below Recent Closing - GuruFocus
Spyre Therapeutics prices public offering at $18.50 per share - Investing.com
Spyre Therapeutics announces pricing of $275 million public offering of common stock - MarketScreener
$275M Offering — Spyre Therapeutics Prices 14.86M Shares for IBD Biotech - Stock Titan
Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock - GlobeNewswire Inc.
Spyre Therapeutics announces common stock offering By Investing.com - Investing.com Nigeria
Spyre Therapeutics Launches Public Offering - MarketScreener
Spyre Therapeutics announces public offering of common stock and pre-funded warrants - MSN
Spyre Therapeutics falls after stock offering launch - TradingView
Spyre Therapeutics announces common stock offering - Investing.com India
Spyre Therapeutics Announces Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Spyre Therapeutics to Offer Common Stock & Pre-Funded Warrants; 30-Day Underwriter Option - Stock Titan
Using Python tools to backtest Spyre Therapeutics Inc. strategiesJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - newser.com
Will Spyre Therapeutics Inc. stock pay special dividendsNew Guidance & Accurate Buy Signal Notifications - newser.com
Why Spyre Therapeutics Inc. stock is a value investor pickQuarterly Trade Review & High Win Rate Trade Tips - newser.com
Spyre Therapeutics (NASDAQ:SYRE) Stock Price Down 5%Here's Why - MarketBeat
Spyre Therapeutics, Inc. (3920.F) stock price, news, quote and history - Yahoo
A Fresh Look at Spyre Therapeutics (SYRE) Valuation Following Encouraging SPY002 Clinical Data and Pipeline Advances - Sahm
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):